Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

ROC curve analysis for ERCC1 with CWP progression. by Hao Deng (409186)

Subjects:

Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. by Cristina Dolciotti (16317330)

Subjects:

The impact of UV360 on the viability and developmental progression of zebrafish embryos. by Lihan Xu (18778257)

Mean ± SD of the different parameters relative to bipedal stance on soft support with the eyes open recorded in the Chewing and Hand Grip groups. by Cristina Dolciotti (16317330)

Subjects:

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)

Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. by Daisuke Sugahara (2047696)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Everolimus decreased IgA1 deposits in glomeruli of α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Everolimus decreased mesangial TfR1 expression in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Decreased expression of tight junction proteins and disruption of intestinal barrier integrity in DSS-induced colitis mouse model. by Mariam Wed Eladham (21439745)

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

Relation of the changes in Y Sway Amplitude and LFS induced by postural training with those in 95% Area. by Cristina Dolciotti (16317330)

Subjects:

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. by Cristina Dolciotti (16317330)

Subjects:

Training-induced changes in bipedal stance. by Cristina Dolciotti (16317330)

Subjects: